| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc. (GLUE) has 6 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. GLUE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 595.0K | $11.11M | -5,466 | |
| Other | 75.0K | $1.40M | - | |
| Other | 67.8K | $1.27M | -6,000 | |
| COO | 62.4K | $1.16M | - | |
| Other | 60.8K | $1.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2021 | Chang Carmen47 | 10% Owner | Buy | 1,050,000 | $19.00 | $19,950,000.00 | +15.8% | +28.8% | -49.9% | |
| Jun 28, 2021 | Bolzon Bradley J Phd75 | Director, 10% Owner | Buy | 157,895 | $19.00 | $3,000,005.00 | +8.1% | +28.8% | -49.9% | |
| Jun 28, 2021 | Baskett Forest53 | 10% Owner | Buy | 1,050,000 | $19.00 | $19,950,000.00 | +15.8% | +28.8% | -49.9% |